Emerging data surround this peptide, a double agonist for GLP-1 and GIP, reveal encouraging capability in treating excess body fat and associated metabolic states. Preliminary studies indicate considerable weight loss https://retatrutideresearchlab.co.uk/product/ozempic-025-mg/